[A clinical study on cefpodoxime proxetil dry syrup in pediatric infections]. 1989

Y Wagatsuma, and A Takase, and N Fukushima, and A Ishikawa, and S Takahashi
Department of Pediatrics, Sapporo City General Hospital.

Clinical studies on cefpodoxime proxetil (CS-807, CPDX-PR) dry syrup were carried out in the field of pediatrics, and the results are summarized as follows. 1. Eleven year-old male and 12 year-old female were administered orally at a dose level of 5.6 and 6.0 mg/kg, respectively, after or before meal. Cmax and T1/2 were 5.0 micrograms/ml and 2.13 hours, respectively, for the male and 4.04 micrograms/ml and 1.63 hours, respectively, for the female. 2. Good clinical responses were obtained in 21 of 22 child patients with bacterial pharyngitis, tonsillitis, scarlet fever and urinary tract infections. One child with Mycoplasma pneumonia did not respond. As to bacteriological effects, eradication of pathogens was observed in 8 out of 11 strains, showing an eradication rate of 72.7%. 3. As to side effect, 1 case of loose stool was observed, but there was no need of discontinuing the drug treatment.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D010612 Pharyngitis Inflammation of the throat (PHARYNX). Sore Throat,Pharyngitides,Sore Throats,Throat, Sore
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097627 Cefpodoxime Proxetil A prodrug of its active metabolite CEFPODOXIME. 1-(Isopropoxycarbonyloxy)ethyl-7-(2-(2-Amino-4-thiazolyl)-2-(Methoxyimino)Acetamido)-3-Methoxymethyl-8-oxo-5-thia-1-Azabicyclo(4,2,0)-oct-2-ene-2-Carboxylate,Cephalosporin 807,Orelox,Otreon,U-76252,CS 807,CS-807,U 76252,Vantin,76252, U,807, CS,807, Cephalosporin,Proxetil, Cefpodoxime,U76252

Related Publications

Y Wagatsuma, and A Takase, and N Fukushima, and A Ishikawa, and S Takahashi
November 1995, Journal of chemotherapy (Florence, Italy),
Y Wagatsuma, and A Takase, and N Fukushima, and A Ishikawa, and S Takahashi
November 1995, Journal of chemotherapy (Florence, Italy),
Y Wagatsuma, and A Takase, and N Fukushima, and A Ishikawa, and S Takahashi
September 1994, The Japanese journal of antibiotics,
Y Wagatsuma, and A Takase, and N Fukushima, and A Ishikawa, and S Takahashi
November 1995, Journal of chemotherapy (Florence, Italy),
Y Wagatsuma, and A Takase, and N Fukushima, and A Ishikawa, and S Takahashi
July 1989, The Japanese journal of antibiotics,
Y Wagatsuma, and A Takase, and N Fukushima, and A Ishikawa, and S Takahashi
July 1989, The Japanese journal of antibiotics,
Y Wagatsuma, and A Takase, and N Fukushima, and A Ishikawa, and S Takahashi
July 1989, The Japanese journal of antibiotics,
Y Wagatsuma, and A Takase, and N Fukushima, and A Ishikawa, and S Takahashi
July 1989, The Japanese journal of antibiotics,
Y Wagatsuma, and A Takase, and N Fukushima, and A Ishikawa, and S Takahashi
July 1989, The Japanese journal of antibiotics,
Y Wagatsuma, and A Takase, and N Fukushima, and A Ishikawa, and S Takahashi
July 1989, The Japanese journal of antibiotics,
Copied contents to your clipboard!